Impact Factor
3.25
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.95
150 total citations
h5-index
16
h5 depth signal
Cited share
66.7%
28 of 42
Total citations
150
Citation footprint
Metric signal
4.90
External metric anchor
Self-citation
0.7%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
964
United States
130
India
113
Iran
79
Germany
63
Citing Fields of Research
Cancer & Development
506
Oncology
471
Noncoding RNA
406
Cancer, Autophagy & Apoptosis
281
Liver & Colon Cancer
215
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,450
Articles tracked across the journal lifetime
Indexed publication set
42
28 cited publications
Last 12 months
10
1.4 publications/month
Open access share
100.0%
10 OA publications in the last year
Leading citing country
China
964 citing publications
Leading citing field
Cancer & Development
506 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v5n1, 1984-
v5n1, 1984-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Clinical Laboratory Science
Cancer & Development
Immunology
Breast Cancer
Prostate Cancer
Issuing & Sponsoring Bodies
Contributor
International Society for Oncodevelopmental Biology and Medicine
Broad Categories
Neoplasms
Lung Cancer
MeSH Descriptors
Carcinoembryonic Antigen
Medical Oncology
Neoplasms
alpha-Fetoproteins
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/14230380261493875
Open DOI
WHO International Standards for tumour markers: Development, characterisation and future perspectives
Background: Measurement of the circulating protein-based tumour markers by immunoassay is used in the routine clinical care of cancer patients, from aiding diagnosis to monitoring disease progression, response to therapy and detecting re...
02
DOI 10.1177/14230380261472771
Open DOI
Beyond proficiency testing: Leveraging commutable External Quality Assessment data to harmonize tumor markers and refine medical decision points
Background: Serum tumor markers such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and prostate-specific antigen (PSA) are crucial to clinical decision-making based on defined medical thresholds. However, significant inter-...
03
DOI 10.1177/14230380261466593
Open DOI
Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds
Background: Prostate-specific antigen (PSA) remains the most widely used biomarker for prostate cancer screening, diagnosis, and monitoring. However, despite decades of standardization efforts, significant inter-assay variability persist...
04
DOI 10.1177/14230380261461490
Open DOI
Digitoxin as a novel synergistic partner of cisplatin in triple-negative breast cancer (TNBC) cells
Background: Triple-negative breast cancer (TNBC) remains clinically challenging due to its aggressive nature, high recurrence rate, and lack of targeted therapies. To address these limitations, combination chemotherapies that synergistic...
05
DOI 10.1177/14230380251408221
Open DOI
Retraction: “LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205”
06
DOI 10.1177/14230380251410478
Open DOI
Tumour markers and evidence-based pathology
Background: Tumour biomarkers have become increasingly important in oncology, shaping cancer diagnostics, classification, and patient management. Despite their potential, the use of cancer biomarkers in clinical settings remains limited....
07
08
DOI 10.1177/14230380251410470
Open DOI
An integrated bioinformatics and multi-omics investigation of the sirtuin family to identify their prognostic importance in human cancers
Background: In recent years, the significance of sirtuins in cancer biology has become increasingly evident, but their molecular mechanisms and prognostic impacts remain elusive. Objective: The present study aimed to investigate the diff...
09
10
Bibliographical & Catalog Notes
Issues for 1987- have title: Tumor biology.
Imprint varies.
Also issued online.
Vol. 5, no. 1 (1984)19911012 Notice published Printed on acid-free paper